Ark Genomic Revolution ETF | ARKG

Medium RiskEquity
Ark Genomic Revolution ETF
Issued by:ARK
Index : AMEX
Unit Price (NAV) :
$
Minimum investment: 1 unit
Share
Compare
Share
Compare
Ark Genomic Revolution ETF | ARKG

Ark Genomic Revolution ETF | ARKG

About ARKG ETF

Overview:
ARK Genomic Revolution ETF invests in companies which are focused on and are expected to substantially benefit from extending and enhancing the quality of human and other life by incorporating technological and scientific developments and advancements in genomics into their business.
The companies held in ARKG may develop, produce or enable:

  • CRISPR
  • Targeted Therapeutics
  • Bioinformatics
  • Molecular Diagnostics
  • Stem Cells
  • Agricultural Biology
ARKG will be concentrated in issuers in any industry or group of industries in the health care sector, including issuers having their principal business activities in the biotechnology industry.
ARKG is an actively managed ETF that seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and U.S. exchange traded foreign equity securities of companies across multiple sectors, including health care, information technology, materials, energy and consumer discretionary, that are relevant to the Fund?s investment theme of the genomics revolution.

Recommended for:
Growth

Returns

PerformanceYTD1Y3Y5Y
Ark Genomic Revolution ETF17.46%219.34%64.52%46.30%

Asset Class

Asset type breakdown
Stock US81.61%
Stock non-US17.52%
Cash0.87%

ARKG Holdings - Top 10

NameiWeightage (%)
CRISPR Therapeutics AG9.28%
Arcturus Therapeutics Holdings Inc8.32%
Invitae Corporation7.67%
Pacific Biosciences of California, Inc6.98%
Twist Bioscience Corporation5.36%
Teladoc Health, Inc4.13%
CareDx, Inc3.61%
Iovance Biotherapeutics, Inc3.29%
Exact Sciences Corporation3.26%
Cellectis S.A3.21%

ARKG Sectors/Industry Breakdown

Sectori% of market value
Healthcare96.67%
Technology2.37%
Consumer Defensive0.78%
Financial Services0.18%

ARKG Countries

Country% of market value
North America82.60%
Europe Developed13.55%
Africa/Middle East2.83%
Japan1.02%

Projected Returns

Investment ofper month
gives returns of :
at 40.90% / annum
$in 5 years
amount
for a time period of
time1Y3Y5Y
Returnsbased on historic SIP returns of 40.90% per annum
$
$
$+ 40.90

ARKG Summary Data

Fund Size(AUM) $i
Avg. mkt. cap (MM) $i
Symbol ARKG
Exchange BATS
Asset class EQUITY

ARKG Portfolio Data & Volatility Analysis

Expense ratio 0.75i
Beta 1.61i
P/E ratio 38.95166i
Standard Deviation 38.65i
Ark Genomic Revolution ETF | ARKG